Biology of interleukin-6. Role in lymphoplasmacytic hemopathies
Levy, Y.; Brouet, J.C.
Annales de Medecine Interne 143(8): 533-543
1992
ISSN/ISBN: 0003-410X PMID: 1303597 Document Number: 396729
Document emailed within 1 workday
Related Documents
Arai, N.; Yokota, T.; de Vries, J.; Banchereau, J.; Takebe, Y.; Lee, F.; Arai, K. 1988: Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4 Developments in Biological Standardization 69: 57-63Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Schilling, V.; Negri, B.; Bujía, J.; Schulz, P.; Kastenbauer, E. 1992: Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear American Journal of Otology 13(4): 350-355
Brown, R.H.; Hamilton, R.G.; Mintz, M.; Jedlicka, A.E.; Scott, A.L.; Kleeberger, S.R. 2005: Genetic predisposition to latex allergy: role of interleukin 13 and interleukin 18 Anesthesiology 102(3): 496-502
Lotze, M.T.; Hellerstedt, B.; Stolinski, L.; Tueting, T.; Wilson, C.; Kinzler, D.; Vu, H.; Rubin, J.T.; Storkus, W.; Tahara, H.; Elder, E.; Whiteside, T. 1997: The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy Cancer Journal from Scientific American 3(Suppl 1): S109-S114
Gillis, S. 1983: Interleukin biochemistry and biology: summary and introduction Federation Proceedings 42(9): 2635-2638
Warrington, R.J. 1988: Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. a role for overproduction of interleukin-2 in human autoimmunity? Journal of Rheumatology 15(4): 616-620
Titov, V.N. 2003: The role of macrophages in inflammation development, effects of interleukin-1, interleukin-6, and hypothalamo-hypophyseal system activity (a literature review) Klinicheskaia Laboratornaia Diagnostika 2003(12): 3-10
Körner, I.J.; Hartwig, M.; Kopp, J. 1988: Human interleukin 2: molecular biology, physiology and clinical possibilities Zeitschrift für Arztliche Fortbildung 82(23): 1171-1174
García de Galdeano; Boyano, D.; Smith-Zubiaga, I.; Alvarez, A.; Cantón, I.; Cañavate, L. 1998: Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells European Cytokine Network 9(2): 187-192
Kasukabe, T.; Okabe-Kado, J.; Hozumi, M.; Honma, Y. 1994: Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes Cancer Research 54(2): 592-597
Polprasert, C.; Wongchitrat, C.; Assanasen, T.; Prayongratana, K. 2009: Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement Journal of the Medical Association of Thailand 92(Suppl 3): S65-S68
Durand, G. 1989: Glycan variants of human alpha 1-acid glycoprotein modulate the biology of macrophages. Evidence that a concanavalin A-unreactive variant is involved in the production of an interleukin 1 inhibitor Progress in Clinical and Biological Research 300: 247-265
Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Rupoli, S.; Logullo, F.; di Bella, P.; Brianzoni, M.F.; Salvi, A.; D'Amico, S.; Olivieri, A.; Leoni, P. 1992: Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load Recenti Progressi in Medicina 83(10): 541-545
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192